Stockscreener 앱 받기
0.3883
0.38%
-0.0015
전일 마감가:
$0.3898
열려 있는:
$0.38
하루 거래량:
430.00K
Relative Volume:
0.03
시가총액:
$16.13M
수익:
$20.27M
순이익/손실:
$-63.80M
주가수익비율:
-0.2555
EPS:
-1.52
순현금흐름:
$-68.35M
1주 성능:
-5.27%
1개월 성능:
-11.97%
6개월 성능:
-11.79%
1년 성능:
-64.70%
1일 변동 폭
$0.3763
$0.39
1주일 범위
$0.3763
$0.4348
52주 변동 폭
$0.1417
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
명칭
Carisma Therapeutics Inc
전화
(267) 491-6422
주소
3675 MARKET STREET, PHILADELPHIA
CARM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.386 | 18.84M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.30 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.73 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.09 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
573.18 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.08 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-04-11 | 개시 | BTIG Research | Buy |
| 2023-10-03 | 개시 | CapitalOne | Overweight |
| 2023-07-06 | 개시 | Evercore ISI | Outperform |
| 2023-05-31 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-05-24 | 개시 | H.C. Wainwright | Buy |
| 2023-04-14 | 개시 | Robert W. Baird | Outperform |
모두보기
Carisma Therapeutics Inc 주식(CARM)의 최신 뉴스
What drives Carisma Therapeutics Inc. stock priceFree Stock Market Real-Time Monitoring - jammulinksnews.com
Carisma Therapeutics Inc. Stock Analysis and ForecastTremendous return on equity - jammulinksnews.com
What analysts say about Carisma Therapeutics Inc. stockBreakout profit opportunities - Autocar Professional
Is Carisma Therapeutics Inc. a good long term investmentFree Risk Assessment Services - jammulinksnews.com
Carisma Therapeutics Transfers Listing to Nasdaq Capital Market - TipRanks
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, CARM, HLGN on Behalf of Shareholders - Benzinga
How Carisma Therapeutics Inc. stock performs during market volatility200 Percent Profit Outlook - Newser
What makes Carisma Therapeutics Inc. stock price move sharplyFree Top-Rated Stock Analysis - Newser
Why Carisma Therapeutics Inc. stock attracts strong analyst attentionFree VIP Investment Strategies - Newser
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TURN, HLGN, CARM, and GNTY - The Malaysian Reserve
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - The Malaysian Reserve
Carisma Therapeutics Inc. (NASDAQ:CARM) Given Average Recommendation of “Hold” by Brokerages - Defense World
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Deal Watch: Novartis To Develop Cardiovascular Therapies With ProFound - insights.citeline.com
After laying off most of its staff, struggling Carisma Therapeutics finds a merger partner - The Business Journals
Carisma Therapeutics, OrthoCellix enter definitive merger agreement - Yahoo Finance
Carisma Therapeutics stock soars after proposed merger with OrthoCellix - Investing.com India
CARISMA Therapeutics Plummets 12%: What Drives a Crash Without News? - AInvest
Carisma Therapeutics' 12% Drop: A Mystery Unveiled Through Order Flow and Peer Dynamics - AInvest
CARISMA Therapeutics Plunges 10.36% Amid Market Volatility - AInvest
Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLC - Defense World
Carisma Therapeutics, Inc. (NASDAQ:CARM) Stock Position Decreased by Millennium Management LLC - Defense World
Millennium Management LLC Takes Position in Marker Therapeutics, Inc. (NASDAQ:MRKR) - Defense World
Carisma Therapeutics Secures Nasdaq Listing Approval - TipRanks
Is the 250% Carisma Therapeutics Stock (CARM) Surge a Sucker’s Rally? - The Globe and Mail
Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga
Carisma Therapeutics Stock (CARM) Retreats 35% After a Massive Rally - TipRanks
US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results - Benzinga
Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews
Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Carisma Therapeutics, Inc. (NASDAQ:CARM) Given Average Recommendation of “Hold” by Brokerages - Defense World
Carisma Therapeutics Reports Q1 2025 Financial Results - TipRanks
Carisma Therapeutics Inc (CARM): An Important Analyst Insights - Stocksregister
Layoff Tracker: Eikon Cuts Workforce by 15%, Citing ‘External Forces’ - BioSpace
Carisma Therapeutics Inc (NASDAQ: CARM) Stock Sentiment: What’s Wall Street Saying? - Stocksregister
Carisma Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Carisma Therapeutics Inc (CARM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
자본화:
|
볼륨(24시간):